Breaking News
Get 50% Off 0
📌 New AI-picked stocks coming soon. 3 picks from last month are already up +30%...
Get early access

Rahul Harkeri

Joined: Jul 10, 2019
  • News

Rahul Harkeri's News
A complete archive of Rahul Harkeri's news items - Page 16

Daqo New Energy Misses Q4 EPS by 224c
Daqo New Energy Misses Q4 EPS by 224c By Investing.com - Feb 28, 2023

Daqo New Energy (NYSE:DQ) reported Q4 EPS of $5.17, $2.24 worse than the analyst estimate of $7.41. Revenue for the quarter came in at $864.3 million versus the consensus estimate...

BMO Financial Group Tops Q1 EPS by 6c
BMO Financial Group Tops Q1 EPS by 6c By Investing.com - Feb 28, 2023

BMO Financial Group (BMO) reported Q1 EPS of Cdn$3.22, Cdn$0.06 better than the analyst estimate of Cdn$3.16. Revenue for the quarter came in at Cdn$6.47 billion versus the...

GSX Techedu Inc. Reports Q4 EPS of RMB0.27
GSX Techedu Inc. Reports Q4 EPS of RMB0.27 By Investing.com - Feb 28, 2023

GSX Techedu Inc. (NYSE:GOTU) reported Q4 EPS of RMB0.27. Revenue for the quarter came in at RMB629.63 million. GUIDANCE: GSX Techedu Inc. sees Q1 2023 revenue of RMB686-706...

ViewRay Tops Q4 EPS by 1c
ViewRay Tops Q4 EPS by 1c By Investing.com - Feb 27, 2023

ViewRay (VRAY) reported Q4 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $34.7 million versus the consensus estimate of...

ForgeRock, Inc Tops Q4 EPS by 1c
ForgeRock, Inc Tops Q4 EPS by 1c By Investing.com - Feb 27, 2023

ForgeRock, Inc (FORG) reported Q4 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $63.52 million versus the consensus estimate...

Freshpet Reports In-Line Q4 EPS
Freshpet Reports In-Line Q4 EPS By Investing.com - Feb 27, 2023

Freshpet (NASDAQ:FRPT) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $165.8 million versus the consensus estimate of...

BeiGene Tops Q4 EPS by 6c
BeiGene Tops Q4 EPS by 6c By Investing.com - Feb 27, 2023

BeiGene (NASDAQ:BGNE) reported Q4 EPS of ($4.29), $0.06 better than the analyst estimate of ($4.35). Revenue for the quarter came in at $380.1 million versus the consensus...